CAREDX, INC. (CDNA)

Import this data to Google Sheets with:

=jivedata("CDNA","financials")

Full statements spill as a table. For one cell: =jivedata("CDNA","Revenue") or =jivedata("CDNA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

CAREDX, INC.

CDNA • CIK 0001217234

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-203,363	$40,765	$-30,781	$108,135
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-190,143	$52,859	$-21,083	$115,192
Income Tax Expense (Benefit)	$141	$310	$271	$4,180
Net Income (Loss) Attributable to Parent	$-190,284	$52,549	$-21,354	$111,012
Revenue from Contract with Customer, Excluding Assessed Tax	$280,324	$333,785	$379,805	$458,089
Research and Development Expense	$81,866	$72,405	$71,429	$79,867
Selling and Marketing Expense	$83,334	$81,718	$102,643	$119,187
General and Administrative Expense	$117,868	$123,784	$107,565	$128,505
Gain (Loss) Related to Litigation Settlement	—	—	$-5,710	$-600
Operating Expenses	$483,687	$293,020	$410,586	$349,954
Interest Income (Expense), Nonoperating, Net	$11,867	$11,765	$9,174	$7,670
Other Nonoperating Income (Expense)	$1,343	$329	$524	$-613
Nonoperating Income (Expense)	$13,220	$12,094	$9,698	$7,057
Weighted Average Number of Shares Outstanding, Basic	53,764,705	52,773,247	53,287,546	49,817,407
Weighted Average Number of Shares Outstanding, Diluted	53,764,705	56,620,590	53,287,546	51,825,963

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$82,197	$114,689	$65,429	$373,636
Marketable Securities, Current	$153,221	$145,964	$111,779	$0
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	$35,246	$33,552	$32,971	$26,838
Accounts Receivable, after Allowance for Credit Loss, Current	$51,061	$64,605	$42,628	$34,377
Operating Lease, Right-of-Use Asset	$29,891	$24,340	$22,760	$16,203
Common Stock, Shares, Outstanding	51,503,377	54,771,203	50,916,644	51,482,536
Inventory, Net	$19,471	$19,503	$26,705	$6,982
Marketable Securities, Noncurrent	—	—	$24,165	$0
Prepaid Expense and Other Assets, Current	$7,763	$7,071	$10,591	$14,228
Intangible Assets, Net (Excluding Goodwill)	$45,701	$38,184	$31,960	$18,556
Assets, Current	$313,713	$351,832	$257,132	$429,223
Goodwill	$40,336	$40,336	$40,336	$35,968
Restricted Cash and Cash Equivalents, Noncurrent	$586	$585	$551	$521
Other Assets, Noncurrent	$1,353	$2,221	$3,353	$5,679
Assets	$466,826	$491,050	$413,228	$532,988
Deferred Income Tax Liabilities, Net	$136	$164	$181	$86
Business Combination, Contingent Consideration, Liability, Noncurrent	—	$174	$161	$161
Operating Lease, Liability, Noncurrent	$28,278	$22,263	$19,679	$13,200
Other Liabilities, Noncurrent	$96,551	$645	$257	$406
Liabilities	$205,498	$112,617	$110,127	$107,390
Accounts Payable, Current	$12,872	$7,686	$9,988	$9,493
Employee-related Liabilities, Current	$19,703	$38,333	$38,107	$34,571
Accrued Liabilities and Other Liabilities	$45,497	$43,352	$41,754	$49,634
Liabilities, Current	$78,072	$89,371	$89,849	$93,698
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$49	$51	$50	$51
Additional Paid in Capital, Common Stock	$946,511	$1,013,193	$1,043,925	$930,993
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-6,963	$-8,569	$-5,515	$0
Retained Earnings (Accumulated Deficit)	$-678,269	$-626,242	$-735,359	$-505,446
Stockholders' Equity Attributable to Parent	$261,328	$378,433	$303,101	$425,598
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	100,000,000	100,000,000	100,000,000	100,000,000
Inventory, Finished Goods, Net of Reserves	$3,658	$4,819	$9,804	$3,049
Inventory, Work in Process, Net of Reserves	$5,191	$3,793	$3,740	$0
Inventory, Raw Materials, Net of Reserves	$10,622	$10,891	$13,161	$3,933
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization	$67,509	$70,494	$71,822	$71,822
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization	$32,263	$36,942	$38,851	$38,851
Depreciation	$7,900	$7,800	$8,700	$8,700
Operating Lease, Liability, Current	$5,943	$6,103	$6,515	$6,047
Accrued Professional Fees, Current	$5,911	$5,971	$4,988	$6,091
Contract with Customer, Liability, Current	$4,748	$4,848	$4,653	$5,547
Customer Refund Liability, Current	—	—	$3,500	$9,531
Other Accrued Liabilities, Current	$2,788	$2,645	$7,317	$10,750

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-190,284	$52,549	$-21,354	$111,012
Net Cash Provided by (Used in) Operating Activities	$-18,388	$38,048	$42,032	$93,658
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$-112	$532	$-90	$4
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-7,660	$32,491	$-49,294	$305,394
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$82,783	$115,274	$65,980	$55,159
Share-based Payment Arrangement, Noncash Expense	$49,086	$66,406	$34,864	$36,966
Proceeds from Sale and Maturity of Marketable Securities	$256,038	$166,921	$154,671	$153,972
Other Asset Impairment Charges	—	—	$0	$0
Payments to Acquire Marketable Securities	$0	$160,286	$145,925	$118,495
Asset Impairment Charges	$1,000	$0	$2,258	$2,258
PaymentsToAcquireEquitySecuritiesFvNi	$965	$634	$0	$0
Depreciation, Depletion and Amortization	$14,386	$14,194	$15,018	$14,406
ProceedsFromSaleOfEquitySecuritiesFvNi	$2,460	$0	$0	$0
Operating Lease, Right-of-Use Asset, Amortization Expense	$5,438	$5,563	$5,398	$5,383
Equity Securities, FV-NI, Realized Gain	$284	$0	$0	$0
Payments to Acquire Intangible Assets	$896	$0	$675	$675
Gain (Loss) on Disposition of Assets	$-44	$-91	$-48	$-167
Payments to Acquire Businesses, Net of Cash Acquired	$6,682	$0	$0	$0
Gain (Loss) on Investments	$2,109	$0	$0	$0
Net Cash Provided by (Used in) Investing Activities	$40,446	$-483	$2,158	$269,081
Fair Value Adjustment of Warrants	$-10	$0	$0	$0
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$2,677	$931	$703	$156
Accretion (Amortization) of Discounts and Premiums, Investments	—	$-621	$-1,273	$-2,125
Increase (Decrease) in Accounts Receivable	$-16,016	$13,741	$-22,521	$-24,819
Payment for Contingent Consideration Liability, Financing Activities	$625	$5,325	$1,500	$1,500
Increase (Decrease) in Inventories	$-54	$1,018	$4,959	$-3,708
Payments for Repurchase of Common Stock	$27,541	$522	$87,768	$50,000
Increase (Decrease) in Prepaid Expenses, Other	$-1,767	$-606	$4,413	$8,622
Proceeds from Warrant Exercises	$4	$0	$0	$0
Increase (Decrease) in Accounts Payable, Trade	$2,904	$-5,110	$808	$42
Proceeds from Stock Options Exercised	$120	$8,936	$5,723	$2,999
Increase (Decrease) in Accrued Salaries	$2,655	$18,667	$-845	$17,837
Proceeds from Stock Plans	$1,495	$1,397	$2,272	$2,497
Increase (Decrease) in Other Accrued Liabilities	$89,608	$-95,661	$-3,308	$2,366
Payment, Tax Withholding, Share-based Payment Arrangement	$3,059	$10,092	$12,121	$11,345
Increase (Decrease) in Royalties Payable	$-1,557	$0	$0	$0
Net Cash Provided by (Used in) Financing Activities	$-29,606	$-5,606	$-93,394	$-57,349
Increase (Decrease) in Deferred Income Taxes	$-566	$187	$-17	$-17
Income Taxes Paid, Net	$738	$317	$284	$284
Capital Expenditures Incurred but Not yet Paid	$647	$633	$3,209	$3,209

Jive Data

Google Sheets add-onSheets Account

Import this data to Google Sheets with:

=jivedata("CDNA","financials")

Full statements spill as a table. For one cell: =jivedata("CDNA","Revenue") or =jivedata("CDNA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

CAREDX, INC.

CDNA • CIK 0001217234

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-203,363	$40,765	$-30,781	$108,135
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-190,143	$52,859	$-21,083	$115,192
Income Tax Expense (Benefit)	$141	$310	$271	$4,180
Net Income (Loss) Attributable to Parent	$-190,284	$52,549	$-21,354	$111,012
Revenue from Contract with Customer, Excluding Assessed Tax	$280,324	$333,785	$379,805	$458,089
Research and Development Expense	$81,866	$72,405	$71,429	$79,867
Selling and Marketing Expense	$83,334	$81,718	$102,643	$119,187
General and Administrative Expense	$117,868	$123,784	$107,565	$128,505
Gain (Loss) Related to Litigation Settlement	—	—	$-5,710	$-600
Operating Expenses	$483,687	$293,020	$410,586	$349,954
Interest Income (Expense), Nonoperating, Net	$11,867	$11,765	$9,174	$7,670
Other Nonoperating Income (Expense)	$1,343	$329	$524	$-613
Nonoperating Income (Expense)	$13,220	$12,094	$9,698	$7,057
Weighted Average Number of Shares Outstanding, Basic	53,764,705	52,773,247	53,287,546	49,817,407
Weighted Average Number of Shares Outstanding, Diluted	53,764,705	56,620,590	53,287,546	51,825,963

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$82,197	$114,689	$65,429	$373,636
Marketable Securities, Current	$153,221	$145,964	$111,779	$0
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	$35,246	$33,552	$32,971	$26,838
Accounts Receivable, after Allowance for Credit Loss, Current	$51,061	$64,605	$42,628	$34,377
Operating Lease, Right-of-Use Asset	$29,891	$24,340	$22,760	$16,203
Common Stock, Shares, Outstanding	51,503,377	54,771,203	50,916,644	51,482,536
Inventory, Net	$19,471	$19,503	$26,705	$6,982
Marketable Securities, Noncurrent	—	—	$24,165	$0
Prepaid Expense and Other Assets, Current	$7,763	$7,071	$10,591	$14,228
Intangible Assets, Net (Excluding Goodwill)	$45,701	$38,184	$31,960	$18,556
Assets, Current	$313,713	$351,832	$257,132	$429,223
Goodwill	$40,336	$40,336	$40,336	$35,968
Restricted Cash and Cash Equivalents, Noncurrent	$586	$585	$551	$521
Other Assets, Noncurrent	$1,353	$2,221	$3,353	$5,679
Assets	$466,826	$491,050	$413,228	$532,988
Deferred Income Tax Liabilities, Net	$136	$164	$181	$86
Business Combination, Contingent Consideration, Liability, Noncurrent	—	$174	$161	$161
Operating Lease, Liability, Noncurrent	$28,278	$22,263	$19,679	$13,200
Other Liabilities, Noncurrent	$96,551	$645	$257	$406
Liabilities	$205,498	$112,617	$110,127	$107,390
Accounts Payable, Current	$12,872	$7,686	$9,988	$9,493
Employee-related Liabilities, Current	$19,703	$38,333	$38,107	$34,571
Accrued Liabilities and Other Liabilities	$45,497	$43,352	$41,754	$49,634
Liabilities, Current	$78,072	$89,371	$89,849	$93,698
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$49	$51	$50	$51
Additional Paid in Capital, Common Stock	$946,511	$1,013,193	$1,043,925	$930,993
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-6,963	$-8,569	$-5,515	$0
Retained Earnings (Accumulated Deficit)	$-678,269	$-626,242	$-735,359	$-505,446
Stockholders' Equity Attributable to Parent	$261,328	$378,433	$303,101	$425,598
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	100,000,000	100,000,000	100,000,000	100,000,000
Inventory, Finished Goods, Net of Reserves	$3,658	$4,819	$9,804	$3,049
Inventory, Work in Process, Net of Reserves	$5,191	$3,793	$3,740	$0
Inventory, Raw Materials, Net of Reserves	$10,622	$10,891	$13,161	$3,933
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization	$67,509	$70,494	$71,822	$71,822
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization	$32,263	$36,942	$38,851	$38,851
Depreciation	$7,900	$7,800	$8,700	$8,700
Operating Lease, Liability, Current	$5,943	$6,103	$6,515	$6,047
Accrued Professional Fees, Current	$5,911	$5,971	$4,988	$6,091
Contract with Customer, Liability, Current	$4,748	$4,848	$4,653	$5,547
Customer Refund Liability, Current	—	—	$3,500	$9,531
Other Accrued Liabilities, Current	$2,788	$2,645	$7,317	$10,750

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-190,284	$52,549	$-21,354	$111,012
Net Cash Provided by (Used in) Operating Activities	$-18,388	$38,048	$42,032	$93,658
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$-112	$532	$-90	$4
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-7,660	$32,491	$-49,294	$305,394
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$82,783	$115,274	$65,980	$55,159
Share-based Payment Arrangement, Noncash Expense	$49,086	$66,406	$34,864	$36,966
Proceeds from Sale and Maturity of Marketable Securities	$256,038	$166,921	$154,671	$153,972
Other Asset Impairment Charges	—	—	$0	$0
Payments to Acquire Marketable Securities	$0	$160,286	$145,925	$118,495
Asset Impairment Charges	$1,000	$0	$2,258	$2,258
PaymentsToAcquireEquitySecuritiesFvNi	$965	$634	$0	$0
Depreciation, Depletion and Amortization	$14,386	$14,194	$15,018	$14,406
ProceedsFromSaleOfEquitySecuritiesFvNi	$2,460	$0	$0	$0
Operating Lease, Right-of-Use Asset, Amortization Expense	$5,438	$5,563	$5,398	$5,383
Equity Securities, FV-NI, Realized Gain	$284	$0	$0	$0
Payments to Acquire Intangible Assets	$896	$0	$675	$675
Gain (Loss) on Disposition of Assets	$-44	$-91	$-48	$-167
Payments to Acquire Businesses, Net of Cash Acquired	$6,682	$0	$0	$0
Gain (Loss) on Investments	$2,109	$0	$0	$0
Net Cash Provided by (Used in) Investing Activities	$40,446	$-483	$2,158	$269,081
Fair Value Adjustment of Warrants	$-10	$0	$0	$0
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$2,677	$931	$703	$156
Accretion (Amortization) of Discounts and Premiums, Investments	—	$-621	$-1,273	$-2,125
Increase (Decrease) in Accounts Receivable	$-16,016	$13,741	$-22,521	$-24,819
Payment for Contingent Consideration Liability, Financing Activities	$625	$5,325	$1,500	$1,500
Increase (Decrease) in Inventories	$-54	$1,018	$4,959	$-3,708
Payments for Repurchase of Common Stock	$27,541	$522	$87,768	$50,000
Increase (Decrease) in Prepaid Expenses, Other	$-1,767	$-606	$4,413	$8,622
Proceeds from Warrant Exercises	$4	$0	$0	$0
Increase (Decrease) in Accounts Payable, Trade	$2,904	$-5,110	$808	$42
Proceeds from Stock Options Exercised	$120	$8,936	$5,723	$2,999
Increase (Decrease) in Accrued Salaries	$2,655	$18,667	$-845	$17,837
Proceeds from Stock Plans	$1,495	$1,397	$2,272	$2,497
Increase (Decrease) in Other Accrued Liabilities	$89,608	$-95,661	$-3,308	$2,366
Payment, Tax Withholding, Share-based Payment Arrangement	$3,059	$10,092	$12,121	$11,345
Increase (Decrease) in Royalties Payable	$-1,557	$0	$0	$0
Net Cash Provided by (Used in) Financing Activities	$-29,606	$-5,606	$-93,394	$-57,349
Increase (Decrease) in Deferred Income Taxes	$-566	$187	$-17	$-17
Income Taxes Paid, Net	$738	$317	$284	$284
Capital Expenditures Incurred but Not yet Paid	$647	$633	$3,209	$3,209

CAREDX, INC.

Consolidated Statementsof Operations

Consolidated Balance Sheets

Consolidated Statementsof Cash Flows

CAREDX, INC.

Consolidated Statementsof Operations

Consolidated Balance Sheets

Consolidated Statementsof Cash Flows